Clinical Trial Update: Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma （HNC-SYSU-005） [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Tirellizumab in combination with TP neoadjuvant therapy for early oral squamous cell carcinoma, currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oral Squamous Cell Carcinoma

Drugs mentioned

• Tirellizumab (Tirellizumab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: HNSCC, PD-1 | Phase 2 | Status: ACTIVE_NOT_RECRUITING